The current patent application deals with the inhibition of signalling through the cytokines IL-4 and IL-13. Pathologically increased activation of this signaling cascade is associated with asthma, atopic dermatitis and related diseases.
Further Information: PDF
GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120
Contact
Beate-Victoria Ermisch
